Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, remains one of the most lethal diseases. Current evidence, discussed in this article, implicates an interplay between the oncogene KRAS, the transcriptional co-activator YES1-Associated Protein (YAP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozengurt, Enrique, Eibl, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533944/
https://www.ncbi.nlm.nih.gov/pubmed/34680275
http://dx.doi.org/10.3390/cancers13205126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533944/
https://www.ncbi.nlm.nih.gov/pubmed/34680275
http://dx.doi.org/10.3390/cancers13205126

Ejemplares similares